Latest Episodes
Prostate cancer: Treatment intensification in mCSPC - The nurse perspective
In this podcast GU NURSES CONNECT members Brenda Martone and Jennifer Sutton discuss the nurse role in managing treatment intensification for metastatic castration sensitive...
Colorectal cancer: Treatment sequencing in advanced mCRC
This podcast episode discusses treatment sequencing in advanced metastatic colorectal cancer (mCRC) patients, third line and beyond. Dr Shubham Pant from MD Anderson Cancer...
Prostate cancer: Which mCSPC patients benefit from early treatment intensification? Case-based discussion
Assoc. Prof. Shilpa Gupta and Dr Fabio Schutz, discuss early treatment intensification with triplet therapy for metastatic castration-sensitive prostate cancer (mCSPC) in this GU...
Prostate cancer: PARP inhibitors. Part 3 - Efficacy and safety of combination therapy
Dr Tanya Dorff, a Medical Oncologist from the City of Hope Comprehensive Cancer Center and Dr Neeraj Agarwal, Medical Oncologist and Director of the...
Advanced HCC: Patients not eligible for IO - What are the treatment options?
Prof. Dr James Harding, Medical Oncologist at Memorial Sloan Kettering Cancer Center and Prof. Dr Sammy Saab, Gastroenterologist and Transplant Hepatologist at the David...
Prostate cancer: PARP inhibitors. Part 2 - Combination therapy; US and EU perspectives
Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro,...